| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.011 | 0.8 |